(Q40326009)

English

Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels

scientific article published on January 2006

Statements

Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels (English)
Robert Wild
Krista Fager
Christine Flefleh
David Kan
Ivan Inigo
Stephen Castaneda
Feng Roger Luo
Amy Camuso
Kelly McGlinchey
William C Rose
1 January 2006
104-113

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit